ESSA Pharma Inc. (EPIX): Price and Financial Metrics


ESSA Pharma Inc. (EPIX)

Today's Latest Price: $6.55 USD

0.06 (0.92%)

Updated Nov 27 1:00pm

Add EPIX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

EPIX Stock Price Chart Interactive Chart >

Price chart for EPIX

EPIX Price/Volume Stats

Current price $6.55 52-week high $8.31
Prev. close $6.49 52-week low $3.00
Day low $6.36 Volume 41,650
Day high $6.73 Avg. volume 76,657
50-day MA $6.46 Dividend yield N/A
200-day MA $5.69 Market Cap 210.02M

ESSA Pharma Inc. (EPIX) Company Bio


ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on the development of novel and proprietary therapies for the treatment of prostate cancer. Its product candidate is EPI-506, an oral small molecule pro-drug that is in Phase 1/2 clinical trial, which blocks the N-terminal domain of the androgen receptor. The company was founded in 2009 and is based in Vancouver, Canada.


EPIX Latest News Stream


Event/Time News Detail
Loading, please wait...

EPIX Latest Social Stream


Loading social stream, please wait...

View Full EPIX Social Stream

Latest EPIX News From Around the Web

Below are the latest news stories about ESSA Pharma Inc that investors may wish to consider to help them evaluate EPIX as an investment opportunity.

The Daily Biotech Pulse: Positive Readout From Galapagos, Intersect ENT Strikes Distribution Deal, Sol Gel's Regulatory Filing Accepted For Review

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 10) Agenus Inc (NASDAQ: AGEN ) Akouos Inc (NASDAQ: AKUS ) BioLife Solutions Inc (NASDAQ: BLFS ) Checkpoint Therapeutics Inc (NASDAQ: CKPT ) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Harmony Biosciences Holdings Inc (NASDAQ: HRMY ) Inspire Medical Systems Inc (NYSE: INSP ) Kintara Therapeutics Inc (NASDAQ: KTRA ) Kura Oncology Inc (NASDAQ: KURA ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) RedHill Biopharma Ltd (NASDAQ: RDHL ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Trillium Therapeutics Inc (NASDAQ: TRIL ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 10) ADiTx Therapeutics Inc (NASDAQ: ADTX ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC )(reac...

Benzinga | September 11, 2020

The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout

Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Abbott Laboratories (NYSE: ABT ) Cancer Genetics Inc (NASDAQ: CGIX ) (announced a deal to buy organoid start up company StemoniX) Cardiff Oncology Inc (NASDAQ: CRDF ) Catabasis Pharmaceuticals Inc (NASDAQ: CATB ) Cerus Corporation (NASDAQ: CERS ) (moved on FDA's emergency use authorization for plasma therapy as a potential COVID-19 treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Fortress Biotech (NASDAQ: FBIO ) Inozyme Pharma Inc (NASDAQ: INZY ) Kamada Ltd. (NASDAQ: KMD) (reacted to the news of EUA for plasma anti-COVID-19 therapy) Keros Therapeutics Inc (NASDAQ: KROS ) Lantern Pharma Inc. (NASDAQ: LTRN ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Principia Biopharma Inc (NASDA...

Benzinga | August 25, 2020

ESSA Pharma EPS beats by $0.06

ESSA Pharma (EPIX): Q3 GAAP EPS of -$0.24 beats by $0.06.Cash of $36.5MPress Release...

Seeking Alpha | August 7, 2020

ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020

VANCOUVER, BC and HOUSTON, Aug. 6, 2020 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ:EPIX) (TSXV:EPI), a …

Benzinga | August 6, 2020

ESSA Pharma completes $49M aggregate gross proceeds

ESSA Pharma ([[EPIX]] -1.5%) announces the closing of an underwritten public offering of 7,100,000 shares at a price of $6 per share.The underwriters were granted a 30-day option to purchase up to an additional 1,065,000 common shares, and the underwriters exercised the option on July 29, 2020.The proceeds from the offering...

Seeking Alpha | July 31, 2020

Read More 'EPIX' Stories Here

EPIX Price Returns

1-mo 14.51%
3-mo -6.70%
6-mo 25.48%
1-year 23.58%
3-year 33.67%
5-year -93.36%
YTD 19.09%
2019 161.90%
2018 -52.05%
2017 -90.00%
2016 -48.47%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7102 seconds.